Breast cancer is the first and most extensively studied malignancy where uPA and PAI-1 are incorporated in clinical practice (Harbeck et al. 1990; Duffy 1996; Duffy et al. 1990, 2014; Schmitt et al. 2010). This evidence concerns the gene SERPINE1 and breast cancer.